Briani, Chiara et al "The BCL2 Inhibitor Venetoclax Plus Rituximab Is Active in MYD88 Wild-Type Polyneuropathy With Anti-MAG Antibodies." Neurology - Neuroimmunology Neuroinflammation 9.4 (2022): 00. Web. 07 Aug. 2022.